Literature DB >> 10858277

Cellular localization of gene expression for progranulin.

R Daniel1, Z He, K P Carmichael, J Halper, A Bateman.   

Abstract

Granulins, also called epithelins, are 6-kD peptides with growth modulatory effects on a variety of cells. The granulin/epithelin precursor supports tumorigenesis in appropriate cell models and is the only growth factor able to overcome the cell cycle block that occurs in murine fibroblasts after deletion of a functional IGF-1 receptor. However, little is known of the role of granulin/epithelin gene products in vivo. To understand the physiological role of granulins it is essential to know the cell types and conditions in which it is expressed. We examined granulin/epithelin gene expression in adult rodents by in situ hybridization. The granulin/epithelin precursor is constitutively expressed in a number of epithelia, particularly in the skin, GI tract, and reproductive system. Other epithelia express the gene less strongly. Progranulin is expressed in immune cells in vivo and in specific neurons in the brain, including Purkinje cells, pyramidal cells of the hippocampus, and some cerebral cortical neurons. Little expression was detected in muscle cell, connective tissue, or endothelium. Cumulatively, these results define the basal gene expression of a new growth factor system and suggest that the progranulin/epithelin gene is multifunctional, with important constitutive roles in epithelial homeostasis, reproductive, immunological, and neuronal function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858277     DOI: 10.1177/002215540004800713

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  139 in total

1.  Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.

Authors:  Ezra Y Rosen; Eric M Wexler; Revital Versano; Giovanni Coppola; Fuying Gao; Kellen D Winden; Michael C Oldham; Lauren Herl Martens; Ping Zhou; Robert V Farese; Daniel H Geschwind
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.

Authors:  Ehab Azab; Kevin Brown Chandler; Yuhei Uda; Ningyuan Sun; Amira Hussein; Raghad Shuwaikan; Veronica Lu; Catherine E Costello; Mark E McComb; Paola Divieti Pajevic
Journal:  FASEB J       Date:  2020-06-18       Impact factor: 5.191

Review 3.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

4.  Novel progranulin mutation detected in 2 patients with FTLD.

Authors:  Lena Skoglund; Toshifumi Matsui; Stefanie H Freeman; Anders Wallin; Elin S Blom; Matthew P Frosch; John H Growdon; Bradley T Hyman; Lars Lannfelt; Martin Ingelsson; Anna Glaser
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

Review 5.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

6.  Progranulin protein levels are differently regulated in plasma and CSF.

Authors:  Alexandra M Nicholson; NiCole A Finch; Colleen S Thomas; Aleksandra Wojtas; Nicola J Rutherford; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; David S Knopman; Ronald C Petersen; Rosa Rademakers
Journal:  Neurology       Date:  2014-04-25       Impact factor: 9.910

Review 7.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 8.  Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia.

Authors:  Edward D Huey; Nicole Armstrong; Parastoo Momeni; Jordan Grafman
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

9.  Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics.

Authors:  Gaurav Ghag; Lauren M Wolf; Randi G Reed; Nicholas P Van Der Munnik; Claudius Mundoma; Melissa A Moss; Vijayaraghavan Rangachari
Journal:  Protein Eng Des Sel       Date:  2016-03-07       Impact factor: 1.650

10.  Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis.

Authors:  Yasuko Yamamoto; Masao Takemura; Ginette Serrero; Jun Hayashi; Binbin Yue; Aya Tsuboi; Hisako Kubo; Takashi Mitsuhashi; Kenji Mannami; Masao Sato; Hidetoshi Matsunami; Yushi Matuo; Kuniaki Saito
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.